Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene Symbol | CD274 | ||||||||||||
| Synonyms | ADMIO5 | B7-H | B7H1 | hPD-L1 | PD-L1 | PDCD1L1 | PDCD1LG1 | PDL1 | ||||||||||||
| Gene Description | CD274 (PD-L1), CD274 molecule, is also known as PD-L1 and is an immunomodulatory ligand, which once bound to its receptor, PD-1 (PDCD1), results in inhibition of T-cell activation (PMID: 24551119) and therefore, is a T cell inhibitory checkpoint protein (PMID: 31940272). CD274 (PD-L1) overexpression has been observed across multiple tumor types and has been associated with CD274 (PD-L1) amplification, specifically in Hodgkin's lymphoma (PMID: 20628145), and CD274 (PD-L1) expression may be indicative of response to immune checkpoint inhibitors in select cancers (PMID: 32269612, PMID: 29097600). | ||||||||||||
|
|||||||||||||
| Variant | Impact | Protein Effect | Variant Description | Associated With Drug Resistance |
|---|
| Variant | Impact | Protein Effect | Variant Description | Associated With Drug Resistance |
|---|
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|